ruthenium has been researched along with Fibrosarcoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bergamo, A; Cemazar, M; Hudej, R; Keppler, BK; Martincic, A; Miklavcic, D; Sava, G; Scancar, J; Sersa, G; Todorovic, V; Turel, I | 1 |
1 other study(ies) available for ruthenium and Fibrosarcoma
Article | Year |
---|---|
Modulation of activity of known cytotoxic ruthenium(III) compound (KP418) with hampered transmembrane transport in electrochemotherapy in vitro and in vivo.
Topics: Animals; Antineoplastic Agents; Biological Transport; Cell Line, Tumor; Cell Membrane; Electrochemotherapy; Electroporation; Fibrosarcoma; In Vitro Techniques; Melanoma, Experimental; Mice; Organometallic Compounds; Ruthenium | 2014 |